Merck's latest campaign for its oncology blockbuster Keytruda emphasizes the passions and talents of people living with cancer. (Credit: Merck)
July 24, 2023 03:04 PM EDT
Pharma
Marketing

Mer­ck evolves Keytru­da ad cam­paign, build­ing on pa­tient in­sights and high­light­ing 16 ap­provals

Beth Snyder Bulik

Senior Editor

Can­cer pa­tients don’t want to be de­fined by their dis­ease. Mer­ck’s lat­est cam­paign for its im­muno-on­col­o­gy block­buster Keytru­da homes in on that in­sight by high­light­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times